CiiTECH

London, United Kingdom Founded: 2017 • Age: 9 yrs
Cannabis therapeutics for neurological disorders and others are developed.

About CiiTECH

CiiTECH is a Consumer company based in London (United Kingdom) founded in 2017. Cannabis therapeutics for neurological disorders and others are developed. CiiTECH has raised $2.91 million across 1 funding round from investors including Fastforward Innovations. Its focus areas include Retail, Cannabis Brands and Retailers, Brands and Application Specific. Its legal entity is CiiTECH LTD. Its competitors include Theros Pharmaceutical, Diem Botanics and Breathe Life Sciences.

Company details

CiiTECH was founded in 2017 and is headquartered in London, United Kingdom. Operations focus on the development of cannabis-based therapeutics within the biotechnology sector. Products are targeted at conditions such as neurological disorders, asthma, liver disease, and obesity. These therapeutics are designed to bind with CB1 and CB2 receptors in the brain, facilitating treatment for various diseases. The companys domain is ciitech.co.il.

  • Headquarters London, United Kingdom
  • Sectors
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ciitech.co.il
  • Social LinkedIn X Facebook
  • Legal Name Ciitech Ltd
Operational Areas
Key Metrics
  • Net Profit
    $581.9 K (USD)
    1771
    as on Dec 31, 2019
  • Total Equity Funding
    $2.91M (USD)

    in 1 rounds

  • Latest Funding Round
    $2.91M (USD), Seed

    Jul 2021

  • Investors

Funding Insights of CiiTECH

CiiTECH has successfully raised a total of $2.91M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.91 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.91M
  • Total Rounds 1
  • Last Round Seed β€” $2.91M
  • First Round $2.91M

    (Jul 2021)

  • Investors Count 1

All 1 funding rounds of CiiTECH with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2021$2.91MSeed–Fastforward Innovations
–
Valuation history

1 investors in total: 1 institutional.

Investors in CiiTECH

CiiTECH has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Fastforward Innovations.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Tech & life Science focused early stage VC firm investing in North America & Europe
2006fstfwd.coSaint Peter Port, Guernsey
Premium access

Investor details for CiiTECH

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of CiiTECH

2 dated milestones of CiiTECH across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded CiiTECH is founded.
  2. Funding First funding round of $2.9M.

Competitors of CiiTECH

CiiTECH has 3 listed competitors in our database. They include Theros Pharmaceutical, Diem Botanics and Breathe Life Sciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
theros.co2012Newcastle Upon Tyne, United Kingdom
Medical cannabis products are developed and branded by Theros Pharmaceutical.
diembotanics.co.uk2019London, United Kingdom
Delivers cannabis-based wellness products to enhance health and well-being.
breathelifesciences.com2021London, United Kingdom
Brand of cannabis medical, health, and wellness products
Premium access

Detailed competitors of CiiTECH

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ciitech

Premium access

Complete news archive for CiiTECH

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CiiTECH

CiiTECH was founded in 2017 and raised its 1st funding round 4 years after it was founded.

CiiTECH is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

CiiTECH is a funded company, having raised a total of $2.91M across 1 funding round to date. The company's 1st funding round was a Seed of $2.91M, raised on Jul 2021.

CiiTECH was founded in 2017 and is headquartered in London, United Kingdom. Operations focus on the development of cannabis-based therapeutics within the biotechnology sector. Products are targeted at conditions such as neurological disorders, asthma, liver disease, and obesity. These therapeutics are designed to bind with CB1 and CB2 receptors in the brain, facilitating treatment for various diseases. The companys domain is ciitech.co.il.

CiiTECH's top competitors include Theros Pharmaceutical, Breathe Life Sciences and Diem Botanics.

CiiTECH has 1 investor. Key investors include Fastforward Innovations.

CiiTECH operates through Ciitech Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available